Companies/US/VVOS

VIVOS THERAPEUTICS, INC.

Last · NASDAQ$0.1727+0.0037 (+2.19%)stale · yahoo · 149h ago
Market cap$3.47M20.1M sh
P/E · TTM-0.1fwd -0.2 · eps -1.88 · loss
Beta6.09vs S&P 500
Div yieldannual · TTM
52w range
$0.1575$4.625
Volume7.4Msession

Issuer

Legal nameVIVOS THERAPEUTICS, INC.
HQUnited States (US)
ListingUS VVOS
ISINUS92859E2072
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0001716166
CIK0001716166
Employees270
AddressVivos Therapeutics, Inc. 7921 Southpark Plaza 80120, Littleton
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.30
Est. revenue
5.5M

Press & signals

3 of 4 recent
  • GlobeNewswire

    Vivos Therapeutics Announces Material Debt Reduction

  • GlobeNewswire

    Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

  • GlobeNewswire

    Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-09-022026-09-080
2026-08-202026-08-210
2026-06-302026-08-140
2026-08-052026-08-110
2026-07-312026-08-030